Animal studies have found that alirocumab treatment rescues liver phenotypes in an alcohol-fed rat model and peripheral PCSK9 inhibition prevents astrocyte and microglial activation and neuroinflammation in a rat model of stroke [110,134]. This evidence concerns the gene PCSK9 and stroke disorder.